Considering the role of miR-708 in breast cancer progression and resistance to therapy, further investigations to evaluate the expression of this miRNA in both the murine and human preclinical mouse models of TNBC- and HER2-positive tumors could prove to be useful. Here, ERBB2 is linked to breast carcinoma.